Angiotensin Receptor Blockers in Aortic Stenosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Angiotensin Receptor Blockers in Aortic Stenosis — Stella

Home/Aortic Stenosis/

View on ClinicalTrials.gov

Recruiting

Back to Aortic Stenosis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Canada

CRIUCPQ, Québec, Quebec

Denmark

Odense University Hospital, Odense

Key details

Phase

Post-approval study

Sponsor

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Collaborators

Odense University Hospital

Enrollment target

~144 participants

Started

February 2020

Primary completion

February 2027

Age range

20 Years – 99 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.